Abstract:Background.Pluripotent stem cells (PSCs) offer immense potential as a source for regenerative therapies.The teratoma assay is widely used in the field of stem cells and regenerative medicine, but the cell composition of teratoma is still elusive. Methods.We utilized PSCs expressing enhanced green fluorescent protein (EGFP) under the control of the Pou5f1 promoter to study the persistence of potential pluripotent cells during teratoma formation in vivo.OCT4-MES (mouse embryonic stem cells) were isolated from the blastocysts of 3.5-day OCT4-EGFP mice (transgenic mice express EGFP cDNA under the control of the Pou5f1 promoter) embryos, and TG iPS 1-7 (induced pluripotent stem cells) were generated from mouse embryonic fibroblasts (MEFs) from 13.5-day OCT4-EGFP mice embryos by infecting them with a virus carrying OCT4, SOX2, KLF4 and c-MYC.These pluripotent cells were characterized according to their morphology and expression of pluripotency markers.Their differentiation ability was studied with in vivo teratoma formation assays.Further differences between pluripotent cells were examined by real-time quantitative PCR (qPCR).Results.The results showed that s everal OCT4-expressing PSCs escaped differentiation inside of teratomas, and these escaped cells (MES-FT, GFP-positive cells separated from OCT4-MES-derived teratomas; and iPS-FT, GFP-positive cells obtained from teratomas formed by TG iPS 1-7) retained their pluripotency.Interestingly, a small number of GFP-positive cells in teratomas formed by MES-FT and iPS-FT ( MES-ST, GFP-positive cells isolated from MES-FT-derived teratomas; iPS-ST, GFP-positive cells obtained from teratomas formed by iPS-FT ) were still pluripotent, as shown by alkaline phosphatase (AP) staining, immunofluorescent staining and PCR.MES-FT, iPS-FT, MES-ST and iPS-ST cells also expressed several markers associated with germ cell formation, such as Dazl, Stella and Stra8.Conclusions.In summary, a small number of PSCs escaped differentiation inside of teratomas , and these cells maintained pluripotency and partially developed towards germ cells.Both escaped PSCs and germ cells present a risk of tumor formation.Therefore, medical workers must be careful in preventing tumor formation when stem cells are used to treat specific diseases.

Research Progress in the Tumorigenicity of Embryonic Stem Cells

Stem Cells and Cellular Origins of Breast Cancer: Updates in the Rationale, Controversies, and Therapeutic Implications

Recent advances in tissue stem cells

[Progress on the Study of Tissue Stem Cells].

The difficulties and progress of research of tumor stem cell

Progress in the Research of Adult Germline Stem Cells

Research Technology Progress in Mammal Inducement of Pluripotent Stem Cells

Progress in Tumor-Stem Cell Theory and Tumor Stem Cells Isolation and Identification

Research Progress in Cancer Stem Cell and Its Microenvironment

Progress on Colon Cancer Stem Cell

Embryonic Stem Cells: in Research

Progress in cancer stem cell research

Recent progress in research on cancer stem cells

Progress in embryonic stem cell-based organ cloning

Hot spots in fundamental stem cell research and their difficulties in application studies

Some recent progress on breast cancer stem cells

Current status of stem cell therapy in China

Research Progress in Inducement of Pluripotent Stem Cells

Progress of the Research on Cancer Stem Cells

Peer Review #1 of "murine Pluripotent Stem Cells That Escape Differentiation Inside Teratomas Maintain Pluripotency (V0.1)"

The Current Research of Stem Cells and its Applications